Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey
- 4 February 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 16 (5), 1005-1014
- https://doi.org/10.1007/s00330-005-0055-7
Abstract
To compare the diagnostic value of whole-body MRI versus radiological skeletal survey (RSS) in staging patients with plasma cell neoplasms (PCN) and to evaluate the possible therapeutic impact of the replacement of RSS by whole-body MRI. Fifty-four patients with PCN [multiple myeloma (MM), n=47; monoclonal gammopathy of unknown significance (MGUS), n=7] were studied by whole-body MRI and RSS in a monocenter prospective analysis from August 2002 to May 2004. The MRIs were performed using a rolling table platform “AngioSURF” for unlimited field of view with a 1.5-T system (Magnetom Sonata/Maestro Class, Siemens Medical Solutions, Erlangen, Germany). A coronal STIR sequence (TR5500-4230/TE102-94/TI160) was used for imaging of the different body regions, including the head, neck, thorax, abdomen, pelvis and upper and lower extremities. The RSS consisted of eight different projections of the axial and appendicular skeleton. In 41/54 (74%) patients, the results of the whole-body MRI and RSS were concordant. In 11/54 (20%) patients, both imaging techniques were negative. Bone involvement was observed in 30/54 (55%) patients; however, whole-body MRI revealed this more extensively than the RSS in 27/30 (90%) patients with concordant positive imaging findings. In 3/30 (10%) patients, both imaging techniques demonstrated a similar extent of bone marrow infiltration. In 10/54 (19%) patients, the whole-body MRI was superior to RSS in detecting bone marrow infiltration, whereas the RSS was negative. In 3/54 (6%) patients, the RSS was proven to be false positive by the clinical course, whereas the whole-body MRI was truly negative. Whole-body MRI is a fast and highly effective method for staging PCN patients by the use of a rolling table platform. Moreover, it is more sensitive and specific than RSS and reveals bone marrow infiltration and extensive disease more reliably. Therefore, whole-body MRI should be performed as an additional method of exactly staging PCN patients and - with more data in the field - may even prove to be an alternate and more sensitive staging procedure than RSS in PCN patients.This publication has 33 references indexed in Scilit:
- Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging SystemInvestigative Radiology, 2005
- Treatment of multiple myelomaBlood, 2004
- Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?Cancer, 2002
- Diagnosis and management of multiple myelomaBritish Journal of Haematology, 2001
- Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young AdultsAmerican Journal of Roentgenology, 2001
- Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-upActa Oncologica, 2000
- Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.American Journal of Roentgenology, 1996
- The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spineBritish Journal of Haematology, 1995
- Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.American Journal of Roentgenology, 1993
- Magnetic Resonance Imaging of the Lower Vertebral Column in Patients with Multiple MyelomaInvestigative Radiology, 1988